TAK-715
Catalog No. A11582
TAK 715是p38 MAPK抑制剂(p38MAPKα的IC50 = 7.1 nM),Wnt /β-catenin信号传导抑制剂,并抑制22种激酶(包括CK1δ/ε)超过80%。
Catalog Num | A11582 |
---|---|
M. Wt | 399.51 |
Formula | C24H21N3OS |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 303162-79-0 |
Synonyms | TAK715, TAK 715 |
SMILES | CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C |
TAK 715是p38 MAPK抑制剂(p38MAPKα的IC50 = 7.1 nM),Wnt /β-catenin信号传导抑制剂,并抑制22种激酶(包括CK1δ/ε)超过80%。
Targets
Target | Value |
---|---|
p38α | IC50: 7.1nM |
p38β | IC50: 0.20μM |
p38γ | IC50: >10μM |
p38δ | IC50: >10μM |
JNK1 | IC50: >10μM |
ERK1 | IC50: >10μM |
IKKβ | IC50: >10μM |
MEKK1 | IC50: >10μM |
TAK1 | IC50: >10μM |
In vitro (25°C) | DMSO | 72 mg/mL (180.22 mM) | |
Water | Insoluble | ||
Ethanol | 14 mg/mL (35.04 mM) | ||
In vivo | 30% propylene glycol, 5% Tween 80, 65% D5W | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 25.03 mL | 125.15 mL | 250.31 mL |
0.5 mM | 5.01 mL | 25.03 mL | 50.06 mL |
1 mM | 2.5 mL | 12.52 mL | 25.03 mL |
5 mM | 0.5 mL | 2.5 mL | 5.01 mL |
*The above data is based on the productmolecular weight 399.51. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.